ID CAN_CAEEL Reviewed; 780 AA. AC P34308; P34309; Q5DX51; Q5DX52; DT 01-FEB-1994, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2005, sequence version 4. DT 27-MAR-2024, entry version 172. DE RecName: Full=Calpain clp-1; DE EC=3.4.22.- {ECO:0000255|PROSITE-ProRule:PRU00239}; GN Name=clp-1 {ECO:0000312|WormBase:C06G4.2a}; GN ORFNames=C06G4.2 {ECO:0000312|WormBase:C06G4.2a}; OS Caenorhabditis elegans. OC Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida; OC Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae; OC Caenorhabditis. OX NCBI_TaxID=6239; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Bristol N2; RX PubMed=7906398; DOI=10.1038/368032a0; RA Wilson R., Ainscough R., Anderson K., Baynes C., Berks M., Bonfield J., RA Burton J., Connell M., Copsey T., Cooper J., Coulson A., Craxton M., RA Dear S., Du Z., Durbin R., Favello A., Fraser A., Fulton L., Gardner A., RA Green P., Hawkins T., Hillier L., Jier M., Johnston L., Jones M., RA Kershaw J., Kirsten J., Laisster N., Latreille P., Lightning J., Lloyd C., RA Mortimore B., O'Callaghan M., Parsons J., Percy C., Rifken L., Roopra A., RA Saunders D., Shownkeen R., Sims M., Smaldon N., Smith A., Smith M., RA Sonnhammer E., Staden R., Sulston J., Thierry-Mieg J., Thomas K., RA Vaudin M., Vaughan K., Waterston R., Watson A., Weinstock L., RA Wilkinson-Sproat J., Wohldman P.; RT "2.2 Mb of contiguous nucleotide sequence from chromosome III of C. RT elegans."; RL Nature 368:32-38(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Bristol N2; RX PubMed=9851916; DOI=10.1126/science.282.5396.2012; RG The C. elegans sequencing consortium; RT "Genome sequence of the nematode C. elegans: a platform for investigating RT biology."; RL Science 282:2012-2018(1998). RN [3] RP FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE. RX PubMed=12410314; DOI=10.1038/nature01108; RA Syntichaki P., Xu K., Driscoll M., Tavernarakis N.; RT "Specific aspartyl and calpain proteases are required for neurodegeneration RT in C. elegans."; RL Nature 419:939-944(2002). RN [4] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=22253611; DOI=10.1371/journal.pgen.1002471; RA Etheridge T., Oczypok E.A., Lehmann S., Fields B.D., Shephard F., RA Jacobson L.A., Szewczyk N.J.; RT "Calpains mediate integrin attachment complex maintenance of adult muscle RT in Caenorhabditis elegans."; RL PLoS Genet. 8:E1002471-E1002471(2012). RN [5] RP FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=22479198; DOI=10.1371/journal.pgen.1002602; RA Joyce P.I., Satija R., Chen M., Kuwabara P.E.; RT "The atypical calpains: evolutionary analyses and roles in Caenorhabditis RT elegans cellular degeneration."; RL PLoS Genet. 8:E1002602-E1002602(2012). CC -!- FUNCTION: Calcium-regulated non-lysosomal thiol-protease which CC catalyzes limited proteolysis of substrates (By similarity). Required CC for assembly and maintenance of integrin attachment complexes which are CC essential for maintenance of adult muscle (PubMed:22253611). CC Proteolytic activity is activated in response to increased CC intracellular Ca(2+) levels during cell degeneration and promotes CC necrotic cell death (PubMed:12410314, PubMed:22479198). CC {ECO:0000250|UniProtKB:P07384, ECO:0000269|PubMed:12410314, CC ECO:0000269|PubMed:22253611, ECO:0000269|PubMed:22479198}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, M line CC {ECO:0000269|PubMed:22479198}. Cytoplasm, myofibril, sarcomere CC {ECO:0000269|PubMed:22479198}. Note=In body wall muscle cells, CC localizes at M-lines extending over the H-zone, and at adhesion plaques CC which form between adjacent cells. {ECO:0000269|PubMed:22479198}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Comment=Experimental confirmation may be lacking for some isoforms.; CC Name=a {ECO:0000312|WormBase:C06G4.2a}; CC IsoId=P34308-1; Sequence=Displayed; CC Name=b {ECO:0000312|WormBase:C06G4.2b}; CC IsoId=P34308-2; Sequence=VSP_005247, VSP_005252; CC Name=c {ECO:0000312|WormBase:C06G4.2c}; CC IsoId=P34308-3; Sequence=VSP_005249, VSP_005251; CC Name=d {ECO:0000312|WormBase:C06G4.2d}; CC IsoId=P34308-4; Sequence=VSP_005248, VSP_005250; CC -!- TISSUE SPECIFICITY: Expressed in muscle and neuronal tissues CC (PubMed:12410314, PubMed:22479198). Expressed in the ventral and dorsal CC nerve cord, intestinal and hypodermal tissues (PubMed:22479198). CC {ECO:0000269|PubMed:12410314, ECO:0000269|PubMed:22479198}. CC -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown results in adult muscle CC defects which include irregularities in sarcomeric structures, CC disorganized integrin attachment complexes, and increased mitochondrial CC fragmentation (PubMed:22253611). RNAi-mediated knockdown in integrin CC attachment complex component mutants unc-112 (e669su250) and unc-52 CC (r367) blocks the protein degradation which normally results from CC complex disruption (PubMed:22253611). RNAi-mediated knockdown CC suppresses cell death in the neurodegenerative models deg-3 (u662), CC gsa-1 (Q227L) and mec-4 (u231) (PubMed:12410314). CC {ECO:0000269|PubMed:12410314, ECO:0000269|PubMed:22253611}. CC -!- SIMILARITY: Belongs to the peptidase C2 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BX284603; CCD63432.1; -; Genomic_DNA. DR EMBL; BX284603; CCD63433.1; -; Genomic_DNA. DR EMBL; BX284603; CCD63434.1; -; Genomic_DNA. DR EMBL; BX284603; CCD63435.1; -; Genomic_DNA. DR PIR; S44749; S44749. DR PIR; S44750; S44750. DR RefSeq; NP_498740.2; NM_066339.5. [P34308-2] DR RefSeq; NP_498741.3; NM_066340.4. [P34308-1] DR RefSeq; NP_741237.1; NM_171886.4. DR RefSeq; NP_741238.1; NM_171201.1. DR AlphaFoldDB; P34308; -. DR SMR; P34308; -. DR BioGRID; 41328; 15. DR STRING; 6239.C06G4.2a.2; -. DR MEROPS; C02.A03; -. DR EPD; P34308; -. DR PaxDb; 6239-C06G4-2a; -. DR PeptideAtlas; P34308; -. DR EnsemblMetazoa; C06G4.2a.1; C06G4.2a.1; WBGene00000542. [P34308-1] DR EnsemblMetazoa; C06G4.2a.2; C06G4.2a.2; WBGene00000542. [P34308-1] DR EnsemblMetazoa; C06G4.2b.1; C06G4.2b.1; WBGene00000542. [P34308-2] DR EnsemblMetazoa; C06G4.2b.2; C06G4.2b.2; WBGene00000542. [P34308-2] DR EnsemblMetazoa; C06G4.2c.1; C06G4.2c.1; WBGene00000542. [P34308-3] DR EnsemblMetazoa; C06G4.2d.1; C06G4.2d.1; WBGene00000542. [P34308-4] DR GeneID; 176122; -. DR KEGG; cel:CELE_C06G4.2; -. DR UCSC; C06G4.2a.1; c. elegans. [P34308-1] DR AGR; WB:WBGene00000542; -. DR WormBase; C06G4.2a; CE37743; WBGene00000542; clp-1. [P34308-1] DR WormBase; C06G4.2b; CE37744; WBGene00000542; clp-1. [P34308-2] DR WormBase; C06G4.2c; CE00517; WBGene00000542; clp-1. [P34308-3] DR WormBase; C06G4.2d; CE30486; WBGene00000542; clp-1. [P34308-4] DR eggNOG; KOG0045; Eukaryota. DR GeneTree; ENSGT00970000196060; -. DR InParanoid; P34308; -. DR OMA; LYMHSAS; -. DR OrthoDB; 142935at2759; -. DR PhylomeDB; P34308; -. DR PRO; PR:P34308; -. DR Proteomes; UP000001940; Chromosome III. DR Bgee; WBGene00000542; Expressed in larva and 4 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0031430; C:M band; IDA:WormBase. DR GO; GO:0030017; C:sarcomere; IDA:WormBase. DR GO; GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:GO_Central. DR GO; GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB. DR GO; GO:0007005; P:mitochondrion organization; IMP:UniProtKB. DR GO; GO:0046716; P:muscle cell cellular homeostasis; IMP:UniProtKB. DR GO; GO:0070266; P:necroptotic process; IGI:WormBase. DR GO; GO:0060298; P:positive regulation of sarcomere organization; IMP:UniProtKB. DR GO; GO:0006508; P:proteolysis; IBA:GO_Central. DR CDD; cd00214; Calpain_III; 1. DR CDD; cd00044; CysPc; 1. DR Gene3D; 2.60.120.380; -; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 1. DR InterPro; IPR033883; C2_III. DR InterPro; IPR022684; Calpain_cysteine_protease. DR InterPro; IPR022682; Calpain_domain_III. DR InterPro; IPR022683; Calpain_III. DR InterPro; IPR036213; Calpain_III_sf. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR000169; Pept_cys_AS. DR InterPro; IPR001300; Peptidase_C2_calpain_cat. DR PANTHER; PTHR10183; CALPAIN; 1. DR PANTHER; PTHR10183:SF379; CALPAIN-A-RELATED; 1. DR Pfam; PF01067; Calpain_III; 1. DR Pfam; PF00648; Peptidase_C2; 1. DR PRINTS; PR00704; CALPAIN. DR SMART; SM00720; calpain_III; 1. DR SMART; SM00230; CysPc; 1. DR SUPFAM; SSF49758; Calpain large subunit, middle domain (domain III); 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR PROSITE; PS50203; CALPAIN_CAT; 1. DR PROSITE; PS00139; THIOL_PROTEASE_CYS; 1. PE 2: Evidence at transcript level; KW Alternative splicing; Cytoplasm; Hydrolase; Protease; Reference proteome; KW Thiol protease. FT CHAIN 1..780 FT /note="Calpain clp-1" FT /id="PRO_0000207734" FT DOMAIN 316..611 FT /note="Calpain catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00239" FT REGION 269..300 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 371 FT /evidence="ECO:0000250|UniProtKB:Q07009" FT ACT_SITE 527 FT /evidence="ECO:0000250|UniProtKB:Q07009" FT ACT_SITE 551 FT /evidence="ECO:0000250|UniProtKB:Q07009" FT VAR_SEQ 76..121 FT /note="Missing (in isoform b)" FT /evidence="ECO:0000305" FT /id="VSP_005247" FT VAR_SEQ 77..113 FT /note="SNYDQGGNGNSGDQQKRKRDMAKDLIGGIFDNVVNRK -> IFIFKIVRQKF FT PKNSSSFFCVRKHLDSLKTSPCGLDQ (in isoform c)" FT /evidence="ECO:0000305" FT /id="VSP_005249" FT VAR_SEQ 77..100 FT /note="SNYDQGGNGNSGDQQKRKRDMAKD -> GGGSGGGGGGNNIGSLVGSLIGGG FT (in isoform d)" FT /evidence="ECO:0000305" FT /id="VSP_005248" FT VAR_SEQ 101..121 FT /note="Missing (in isoform d)" FT /evidence="ECO:0000305" FT /id="VSP_005250" FT VAR_SEQ 114..780 FT /note="Missing (in isoform c)" FT /evidence="ECO:0000305" FT /id="VSP_005251" FT VAR_SEQ 708 FT /note="D -> DMNN (in isoform b)" FT /evidence="ECO:0000305" FT /id="VSP_005252" SQ SEQUENCE 780 AA; 83643 MW; C1DFA4E5671F7835 CRC64; MADDEEEIIQ KVEVKPDEFN GLIGSIAGNL IRDKVGGAGG DILGGLASNF FGGGGGGGGG GGGGGFGGGN GGFGGGSNYD QGGNGNSGDQ QKRKRDMAKD LIGGIFDNVV NRKGKKEQDN YGGGGNYGGG GGNQGGGGGG GFNFNDIGGL INSMGGGGGG GQRQGGGGGG FGDILGGIGS LIGGGGGGQY NGGGGNVNPN NLNGGMVNVI GNLIGEAAHR FLGVDPGTGR IIGAVAGNVI MGLGGKDNSL GNIGKVILDN IISGKFRRDV DPFVRPGPDP DRGGGGSGPS PISPRPTTEP QDFYELRDQC LESKRLFEDP QFLANDSSLF FSKRPPKRVE WLRPGEITRE PQLITEGHSR FDVIQGELGD CWLLAAAANL TLKDELFYRV VPPDQSFTEN YAGIFHFQFW QYGKWVDVVI DDRLPTSNGE LLYMHSASNN EFWSALLEKA YAKLFGSYEA LKGGTTSEAL EDMTGGLTEF IDLKNPPRNL MQMMMRGFEM GSLFGCSIEA DPNVWEAKMS NGLVKGHAYS ITGCRIVDGP NGQTCILRIR NPWGNEQEWN GPWSDNSREW RSVPDSVKQD MGLKFDHDGE FWMSFDDFMR NFEKMEICNL GPDVMDEVYQ MTGVKAAGMV WAANTHDGAW VRNQTAGGCR NYINTFANNP QFRVQLTDSD PDDDDELCTV IFAVLQKYRR NLKQDGLDNV PIGFAVYDAG NNRGRLSKQF FAANKSAMRS AAFINLREMT GRFRVPPGNY VVVPSTFEPN EEAEFMLRVY TNGFIESEEL //